activity
20202023
most citedA cross-study analysis of drug response prediction in cancer cell lines

9 citations · 26 across the 5 of their papers we have counts for

collaborators

6 papers

q-bio.QM2023

Influencing factors on false positive rates when classifying tumor cell line response to drug treatment

Priyanka Vasanthakumari, Thomas Brettin, Yitan Zhu +6

Informed selection of drug candidates for laboratory experimentation provides an efficient means of identifying suitable anti-cancer treatments. The advancement of artificial intel…

q-bio.BM2021★ 2 cited

Protein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening

Austin Clyde, Thomas Brettin, Alexander Partin +8

We propose a benchmark to study surrogate model accuracy for protein-ligand docking. We share a dataset consisting of 200 million 3D complex structures and 2D structure scores acro…

q-bio.QM2021★ 9 cited

A cross-study analysis of drug response prediction in cancer cell lines

Fangfang Xia, Jonathan Allen, Prasanna Balaprakash +21

To enable personalized cancer treatment, machine learning models have been developed to predict drug response as a function of tumor and drug features. However, most algorithm deve…

q-bio.QM2020

Learning Curves for Drug Response Prediction in Cancer Cell Lines

Alexander Partin, Thomas Brettin, Yvonne A. Evrard +9

Motivated by the size of cell line drug sensitivity data, researchers have been developing machine learning (ML) models for predicting drug response to advance cancer treatment. As…

q-bio.QM2020★ 8 cited

Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response

Yitan Zhu, Thomas Brettin, Yvonne A. Evrard +6

Transfer learning has been shown to be effective in many applications in which training data for the target problem are limited but data for a related (source) problem are abundant…

cs.LG2020★ 7 cited

A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning

Austin Clyde, Tom Brettin, Alexander Partin +6

By combining various cancer cell line (CCL) drug screening panels, the size of the data has grown significantly to begin understanding how advances in deep learning can advance dru…